Skip to Content

Virulizin FDA Approval Status

FDA Approved: No
Brand name: Virulizin
Company: Lorus Therapeutics Inc.
Treatment for: Pancreatic Cancer

Virulizin is a biologic response modifier in development for the treatment of pancreatic cancer.

Development Timeline for Virulizin

DateArticle
Jun 13, 2005U.S. FDA Agrees to Rolling New Drug Application for Virulizin

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.